ATCC
History
| Year | Detail |
|---|---|
| 1925 | ATCC was founded in 1925 as a private, nonprofit biotechnology organization. |
| 1967 | ATCC accepted plant viruses to support research in various biomedical disciplines, from nanotechnology to vaccine development. |
| 1998 | The company established a new headquarters in Manassas, Virginia. |
| 2023 | The company's NIH HIV Reagent Program was merged with BEI Resources to enable streamlined access to all priority pathogens for human health under one program. |
| 2023 | ATCC and the U.S. Pharmacopeia (USP), an independent, international, and scientific nonprofit organization, collaborated to jointly provide co-branded reference materials and reference standards that advance the quality and development of biologic medicines and therapies. |
| 2024 | The company collaborated with Tissue Dynamics, a disruptive pharma-tech company, to develop workflow-friendly cardiac organoids-based kits for improved cardiac safety testing in drug development. |
BCC Research Beacon 